Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Metabotropic glutamate receptor 3 (mGluR3), encoded by the GRM3 gene, is a Class C G protein-coupled receptor that is negatively coupled to adenylate cyclase via Gi/Go proteins. It is widely expressed in the central nervous system, particularly in neurons and astrocytes, where it acts as an inhibitory autoreceptor and heteroceptor to regulate extracellular glutamate levels and synaptic plasticity. In primates, mGluR3 is also localized postsynaptically in the prefrontal cortex, where it plays a critical role in supporting higher cognitive functions such as working memory.\n\nGenetic variations and deficits in GRM3 signaling are strongly associated with psychiatric and cognitive disorders, most notably schizophrenia, bipolar disorder, and major depressive disorder. Pharmacological modulation of mGluR3 using agonists, antagonists, or allosteric modulators represents a promising therapeutic strategy for neuropsychiatric conditions and neurodegenerative diseases like Alzheimer's and Parkinson's. Additionally, emerging research highlights mGluR3 as a potential target in oncology, particularly in glioblastoma, where its inhibition can disrupt tumor cell self-renewal and promote differentiation.
Agonist, antagonist, negative allosteric modulator, or positive allosteric modulator of metabotropic glutamate receptor 3
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Metabotropic glutamate receptor 3 (mGluR3) (mGluR3).